Morgan Stanley maintains Chugai Pharmaceutical at Overweight, PT $4520.00

  • Investing.com
Morgan Stanley maintains Chugai Pharmaceutical at Overweight, PT $4520.00

A Morgan Stanley analyst maintained Chugai Pharmaceutical (TYO: 4519) at Overweight and a price target of $4520.00 from a prior price target of %currency%%price%.

Prior to this rating, Chugai Pharmaceutical had 7 buy ratings, 4 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Chugai Pharmaceutical, click here. For more news on Chugai Pharmaceutical, click here.

Chugai Pharmaceutical's stock price closed at $3.0. They are down -99.91% in the last month and down -6.8% in the last 12 months.

According to Investing Pro, Chugai Pharmaceutical's fair value is $3.3K, an upside of -7.5%. Chugai Pharmaceutical's fair value comes with a medium degree of uncertainty, according to InvestingPro.

Check out Chugai Pharmaceutical's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles